Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIEVE: Acetazolamide in Heart Failure
NCT07737964Phase 3Not yet recruiting
- Sponsor
- CHU Montpellier
- Start
- Oct 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in heart failure (HF), sponsored by CHU Montpellier. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
acetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07737964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737964.